MA20150243A1 - Préparation thérapeutique et procédé de préparation de ladite préparation thérapeutique - Google Patents
Préparation thérapeutique et procédé de préparation de ladite préparation thérapeutiqueInfo
- Publication number
- MA20150243A1 MA20150243A1 MA37392A MA37392A MA20150243A1 MA 20150243 A1 MA20150243 A1 MA 20150243A1 MA 37392 A MA37392 A MA 37392A MA 37392 A MA37392 A MA 37392A MA 20150243 A1 MA20150243 A1 MA 20150243A1
- Authority
- MA
- Morocco
- Prior art keywords
- therapeutic preparation
- preparing
- therapeutic
- preparation
- platelet concentrate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
L'invention concerne une préparation thérapeutique (1) comprenant de l'huile ozonisée et un concentrat plaquettaire (2), mélangée selon un rapport de mélange entre les volumes du concentrat plaquettaire (2) et de l'huile ozonisée (3) substantiellement dans la plage comprise entre 2 et 4.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000338A ITMI20120338A1 (it) | 2012-03-06 | 2012-03-06 | Preparato terapeutico e procedimento di preparazione di detto preparato terapeutico |
PCT/IB2013/051739 WO2013132428A1 (fr) | 2012-03-06 | 2013-03-05 | Préparation thérapeutique et procédé de préparation de ladite préparation thérapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
MA20150243A1 true MA20150243A1 (fr) | 2015-07-31 |
Family
ID=45999974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA37392A MA20150243A1 (fr) | 2012-03-06 | 2013-03-05 | Préparation thérapeutique et procédé de préparation de ladite préparation thérapeutique |
Country Status (18)
Country | Link |
---|---|
US (1) | US20150071893A1 (fr) |
EP (1) | EP2822562A1 (fr) |
JP (1) | JP2015512886A (fr) |
CN (1) | CN104254335A (fr) |
AP (1) | AP2014007991A0 (fr) |
AU (1) | AU2013229128A1 (fr) |
CA (1) | CA2869364A1 (fr) |
EA (1) | EA201400985A1 (fr) |
IT (1) | ITMI20120338A1 (fr) |
MA (1) | MA20150243A1 (fr) |
MD (1) | MD20140110A2 (fr) |
MX (1) | MX2014010686A (fr) |
NZ (1) | NZ700661A (fr) |
PH (1) | PH12014502261A1 (fr) |
SG (1) | SG11201405500YA (fr) |
TN (1) | TN2014000378A1 (fr) |
WO (1) | WO2013132428A1 (fr) |
ZA (1) | ZA201407214B (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2644650C2 (ru) | 2014-12-01 | 2018-02-13 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток и способ его получения |
RU2708329C2 (ru) | 2016-05-31 | 2019-12-05 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток, композиции и способы применения |
CN106615687A (zh) * | 2016-11-21 | 2017-05-10 | 肖成运 | 一种新型的复合饲料添加剂 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5336488A (en) * | 1991-08-07 | 1994-08-09 | American Cyanamid Company | Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines |
JPH0971536A (ja) * | 1995-07-03 | 1997-03-18 | Nippon Telegr & Teleph Corp <Ntt> | 生物細胞含有液凍結乾燥装置 |
AT407484B (de) * | 1997-11-12 | 2001-03-26 | Bio Prod & Bio Eng Ag | Arzneimittel zur förderung der wundheilung |
US6472210B1 (en) * | 1997-11-14 | 2002-10-29 | Bonetec Corporation | Polymer scaffold having microporous polymer struts defining interconnected macropores |
JP3993981B2 (ja) * | 1998-06-22 | 2007-10-17 | サイトメディックス・インコーポレーテッド | 改良された濃縮血小板創傷治癒剤に対する特許の適用 |
DE69915204T2 (de) * | 1998-08-17 | 2004-07-29 | Pfizer Products Inc., Groton | Stabilisierte Proteinzusammensetzung |
CA2296997A1 (fr) * | 2000-01-18 | 2001-07-18 | Vasogen Ireland Limited | Traitement de l'insuffisance cardiaque globale |
TR200401573T4 (tr) * | 2000-02-29 | 2004-08-23 | Pfizer Products Inc. | Stabilize edilmiş granülosit koloni uyarıcı faktör |
RU2201756C2 (ru) * | 2001-03-11 | 2003-04-10 | Вятская государственная сельскохозяйственная академия | Способ профилактики и лечения мастита у коров |
WO2002100455A2 (fr) * | 2001-06-08 | 2002-12-19 | Baylor College Of Medicine | Dispositifs medicaux ozones et methodes d'utilisation de l'ozone pour eviter les complications liees aux dispositifs medicaux installes a demeure |
RU2238097C2 (ru) * | 2002-05-24 | 2004-10-20 | Вятская государственная сельскохозяйственная академия | Препарат для лечения и профилактики эндометрита и мастита у коров и способ его приготовления |
JP2005112798A (ja) * | 2003-10-08 | 2005-04-28 | Atsuya Ogata | 動物の炎症又は創傷を治療するための外用治療薬及び治療方法 |
BRPI0520280A2 (pt) * | 2005-05-10 | 2009-04-28 | Us Of America Dept Of Veteran | terapia de disfunÇÕes renais e falÊncia méltipla de àrgços com cÉlulas-tronco mesenquimais e meio condicionado por exposiÇço a cÉlulas-tronco mesenquimais |
BE1017155A3 (nl) * | 2006-06-01 | 2008-03-04 | Sanomedical Bvba | Wondverzorgingsproduct. |
CN201029956Y (zh) * | 2007-05-29 | 2008-03-05 | 张全有 | 动物乳腺炎治疗仪 |
JP2009235004A (ja) * | 2008-03-27 | 2009-10-15 | J Hewitt Kk | 細胞組織増加促進方法及び肌問題改善方法並びにこれらに用いるキット |
-
2012
- 2012-03-06 IT IT000338A patent/ITMI20120338A1/it unknown
-
2013
- 2013-03-05 JP JP2014560493A patent/JP2015512886A/ja active Pending
- 2013-03-05 NZ NZ700661A patent/NZ700661A/en not_active IP Right Cessation
- 2013-03-05 SG SG11201405500YA patent/SG11201405500YA/en unknown
- 2013-03-05 AU AU2013229128A patent/AU2013229128A1/en not_active Abandoned
- 2013-03-05 MX MX2014010686A patent/MX2014010686A/es unknown
- 2013-03-05 CA CA2869364A patent/CA2869364A1/fr not_active Abandoned
- 2013-03-05 AP AP2014007991A patent/AP2014007991A0/xx unknown
- 2013-03-05 US US14/382,893 patent/US20150071893A1/en not_active Abandoned
- 2013-03-05 MA MA37392A patent/MA20150243A1/fr unknown
- 2013-03-05 MD MDA20140110A patent/MD20140110A2/ro not_active Application Discontinuation
- 2013-03-05 EA EA201400985A patent/EA201400985A1/ru unknown
- 2013-03-05 WO PCT/IB2013/051739 patent/WO2013132428A1/fr active Application Filing
- 2013-03-05 CN CN201380021665.4A patent/CN104254335A/zh active Pending
- 2013-03-05 EP EP13720053.1A patent/EP2822562A1/fr not_active Withdrawn
-
2014
- 2014-09-04 TN TNP2014000378A patent/TN2014000378A1/fr unknown
- 2014-10-06 ZA ZA2014/07214A patent/ZA201407214B/en unknown
- 2014-10-07 PH PH12014502261A patent/PH12014502261A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2015512886A (ja) | 2015-04-30 |
US20150071893A1 (en) | 2015-03-12 |
PH12014502261A1 (en) | 2014-12-15 |
ITMI20120338A1 (it) | 2013-09-07 |
AP2014007991A0 (en) | 2014-10-31 |
CA2869364A1 (fr) | 2013-09-12 |
AU2013229128A1 (en) | 2014-10-23 |
MX2014010686A (es) | 2015-04-10 |
EA201400985A1 (ru) | 2015-04-30 |
SG11201405500YA (en) | 2014-10-30 |
ZA201407214B (en) | 2015-10-28 |
MD20140110A2 (ro) | 2015-03-31 |
WO2013132428A1 (fr) | 2013-09-12 |
NZ700661A (en) | 2016-08-26 |
TN2014000378A1 (en) | 2015-12-21 |
EP2822562A1 (fr) | 2015-01-14 |
CN104254335A (zh) | 2014-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014029752A2 (pt) | uso de n-metil-n-acilglucaminas como estabilizadores de frio em soluções de tensoativos | |
FR2983077B1 (fr) | Seringue | |
BR112014029762A2 (pt) | composição contendo n-metil-n-acilglucamina | |
MY183637A (en) | Compounds and uses thereof for the modulation of hemoglobin | |
EA201690998A1 (ru) | НОВЫЕ СОЕДИНЕНИЯ 3,5-ДИЗАМЕЩЕННОГО-3H-ИМИДАЗО[4,5-b]ПИРИДИНА И 3,5-ДИЗАМЕЩЕННОГО-3H-[1,2,3]ТРИАЗОЛО[4,5-b]ПИРИДИНА КАК МОДУЛЯТОРЫ ПРОТЕИНКИНАЗ | |
BRPI0607728A2 (pt) | complexo de lipoproteìna carregado reconstituìdo, composição farmacêutica, e, uso de um complexo de lipoproteìna carregado | |
MX370903B (es) | Composiciones de ácido percarboxílico estables y sus usos. | |
BR112014027535A2 (pt) | mesa elevatória tipo tesoura e método para construção de uma mesa elevatória tipo tesoura | |
EA201390162A1 (ru) | Противораковые соединения, их получение и их терапевтическое применение | |
EA201491520A1 (ru) | НОВЫЕ СОЕДИНЕНИЯ 3,5-ДИЗАМЕЩЕННОГО-3H-ИМИДАЗО[4,5-b]ПИРИДИНА И 3,5-ДИЗАМЕЩЕННОГО-3H-[1,2,3]ТРИАЗОЛО[4,5-b]ПИРИДИНА КАК МОДУЛЯТОРЫ C-met ПРОТЕИНКИНАЗ | |
EA201992707A1 (ru) | Соединения и их применения для модуляции гемоглобина | |
MA38633B1 (fr) | Système à lots multiples pour la préparation d'une solution de bicarbonate de calcium convenant à la reminéralisation d'eau dessalée et d'eau naturellement douce | |
MA38555A1 (fr) | Dérivés de pyrrolo[2,3-d]pyrimidine en tant qu'agonistes du récepteur cb2 | |
CO7160080A2 (es) | Composiciones lipídicas de racecadotrillo | |
MA20150243A1 (fr) | Préparation thérapeutique et procédé de préparation de ladite préparation thérapeutique | |
MA35043B1 (fr) | Formulation pharmaceutique comprenant de l'inositol | |
EP4293116A3 (fr) | Fibrinogène liquide stable | |
MA34840B1 (fr) | Dérivés monoterpènes de chalcone ou de dihydrochalcone, et leur utilisation en tant qu'agents de dépigmentation | |
RU2012144232A (ru) | Грунтовая смесь для дорожного строительства (варианты) | |
PH12014501176A1 (en) | Anticoagulant reversal agents | |
EA201692234A1 (ru) | Композиция в форме эмульсии "масло-в-воде", содержащая молотое семя белой или желтой горчицы | |
MA42166A1 (fr) | Seringue | |
WO2013021398A3 (fr) | Procédé de préparation du chlorure de mivacurium | |
MA39027A1 (fr) | Pyrido[4,3-b]pyrazine-2-carboxamides utilisées en tant qu'agents neurogènes dans le traitement des troubles neurodégénératifs | |
MA37438A1 (fr) | Procédés de traitement du cancer utilisant des inhibiteurs de la kinase aurora |